Suchergebnisse - "Wang, Bingxia"

PubPharm (86)

1

A WOx/MoOx hybrid oxide based SERS FET and investigation on its tunable SERS performance

enthalten in: Physical chemistry chemical physics : PCCP | 2024

von Yuan, K. | Qian, Q. | Wu, M. | +6

2

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone

enthalten in: Haematologica | 2024

von Ramasamy, K. | Bahlis, N. | Kumar, S. | +7

3

Nonlinear photonic crystals for completely independent asymmetric holographic imaging

enthalten in: Optics letters | 2024

von Wang, B. | Li, Y. | Shen, X.

4

Experimental study on alkali reduction of film-coated porous ecological concrete by microbial calcium carbonate precipitation technology

enthalten in: Scientific reports | 2024

von Wang, B. | Yang, B. | Wang, L. | +2

5

Asymmetric wavefront shaping with nonreciprocal 3D nonlinear detour phase hologram

enthalten in: Optics express | 2023

von Wang, B. | Li, Y. | Shen, X. | +1

6

Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients : An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Bringhen, S. | Pour, L. | Benjamin, R. | +11

7

Single cell molecular alterations reveal target cells and pathways of conditioned fear memory

enthalten in: Brain research | 2023

von Shen, M. | Shang, M. | Tian, R. | +9

8

Moderate white light exposure enhanced spatial memory retrieval by activating a central amygdala-involved circuit in mice

enthalten in: Communications biology | 2023

von Shang, M. | Shen, M. | Xu, R. | +14

9

MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials

enthalten in: Blood | 2023

von Paiva, B. | Manrique, I. | Dimopoulos, M. | +17

CommentIn: Blood. 2023 Feb 9;141(6):557-558. - PMID 36757729

10

Bias and Type I error Control in Correcting Treatment Effect for Treatment Switching Using Marginal Structural Models in Phase III Oncology Trials

enthalten in: Journal of biopharmaceutical statistics | 2022

von Xu, J. | Liu, G. | Wang, B.

1
2
3
4
5
6
7
8
9
Nächster »
[9]